14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
HQL vs THQ: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, abrdn Life Sciences Investors (HQL) captures the overall head-to-head institutional edge over abrdn Healthcare Opportunities Fund (THQ) on higher Unified Composite conviction (46.0/100 HOLD vs. 45.8/100 HOLD) after splitting the core matrix 1–3 (led by composite factor balance), while THQ wins 1–0 across the 6-pillar growth and valuation breakdown. HQL trades at $17.76 (N/M Forward P/E, N/A operating margin) versus THQ at $18.82 (N/M Forward P/E, N/A operating margin).
Growth vs. Quality Trade-Off: HQL earns the overall head-to-head edge with a stronger Unified Composite Score (46.0/100 HOLD vs. THQ 45.8/100 HOLD) and 0.90β · 39% Vol risk profile, whereas THQ leads top-line expansion (N/A YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on HQL vs THQ. Trailing 12-month operating profitability (HQL N/A vs THQ N/A) and valuation multiples (HQL N/M vs THQ N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with $734.5M market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ HQL vs THQ Key Questions & Quantitative Answers
As of Nov 16, 2026, abrdn Life Sciences Investors (HQL) captures the overall head-to-head institutional edge over abrdn Healthcare Opportunities Fund (THQ) on higher Unified Composite conviction (46.0/100 HOLD vs. 45.8/100 HOLD) after splitting the core matrix 1–3 (led by composite factor balance), while THQ wins 1–0 across the 6-pillar growth and valuation breakdown. HQL trades at $17.76 (N/M Forward P/E, N/A operating margin) versus THQ at $18.82 (N/M Forward P/E, N/A operating margin). Growth vs. Quality Trade-Off: HQL earns the overall head-to-head edge with a stronger Unified Composite Score (46.0/100 HOLD vs. THQ 45.8/100 HOLD) and 0.90β · 39% Vol risk profile, whereas THQ leads top-line expansion (N/A YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates.
THQ leads the Growth & Scale pillar: HQL posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with THQ at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, HQL generates N/A in USD-normalized revenue versus N/A for THQ. In operating R&D and SG&A reinvestment, HQL deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for THQ.
HQL and THQ trade at balanced relative valuation multiples. HQL trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas THQ trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against HQL (N/A ROE) versus THQ (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, HQL carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.90β · 39% Vol realized risk). By comparison, THQ carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.52β · 23% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.